Cargando…

Individualized Prediction of Colorectal Cancer Metastasis Using a Radiogenomics Approach

Objectives: To evaluate whether incorporating the radiomics, genomics, and clinical features allows prediction of metastasis in colorectal cancer (CRC) and to develop a preoperative nomogram for predicting metastasis. Methods: We retrospectively analyzed radiomics features of computed tomography (CT...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Qin, Li, Jie, Xu, Lin, Wang, Jiasi, Zeng, Zhaoping, Fu, Jiangping, Huang, Xuan, Chu, Yanpeng, Wang, Jing, Zhang, Hong-Yu, Zeng, Fanxin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8113949/
https://www.ncbi.nlm.nih.gov/pubmed/33996544
http://dx.doi.org/10.3389/fonc.2021.620945
_version_ 1783690969958318080
author Liu, Qin
Li, Jie
Xu, Lin
Wang, Jiasi
Zeng, Zhaoping
Fu, Jiangping
Huang, Xuan
Chu, Yanpeng
Wang, Jing
Zhang, Hong-Yu
Zeng, Fanxin
author_facet Liu, Qin
Li, Jie
Xu, Lin
Wang, Jiasi
Zeng, Zhaoping
Fu, Jiangping
Huang, Xuan
Chu, Yanpeng
Wang, Jing
Zhang, Hong-Yu
Zeng, Fanxin
author_sort Liu, Qin
collection PubMed
description Objectives: To evaluate whether incorporating the radiomics, genomics, and clinical features allows prediction of metastasis in colorectal cancer (CRC) and to develop a preoperative nomogram for predicting metastasis. Methods: We retrospectively analyzed radiomics features of computed tomography (CT) images in 134 patients (62 in the primary cohort, 28 in the validation cohort, and 44 in the independent-test cohort) clinicopathologically diagnosed with CRC at Dazhou Central Hospital from February 2018 to October 2019. Tumor tissues were collected from all patients for RNA sequencing, and clinical data were obtained from medical records. A total of 854 radiomics features were extracted from enhanced venous-phase CT of CRC. Least absolute shrinkage and selection operator regression analysis was utilized for data dimension reduction, feature screen, and radiomics signature development. Multivariable logistic regression analysis was performed to build a multiscale predicting model incorporating the radiomics, genomics, and clinical features. The receiver operating characteristic curve, calibration curve, and decision curve were conducted to evaluate the performance of the nomogram. Results: The radiomics signature based on 16 selected radiomics features showed good performance in metastasis assessment in both primary [area under the curve (AUC) = 0.945, 95% confidence interval (CI) 0.892–0.998] and validation cohorts (AUC = 0.754, 95% CI 0.570–0.938). The multiscale nomogram model contained radiomics features signatures, four-gene expression related to cell cycle pathway, and CA 19-9 level. The multiscale model showed good discrimination performance in the primary cohort (AUC = 0.981, 95% CI 0.953–1.000), the validation cohort (AUC = 0.822, 95% CI 0.635–1.000), and the independent-test cohort (AUC = 0.752, 95% CI 0.608–0.896) and good calibration. Decision curve analysis confirmed the clinical application value of the multiscale model. Conclusion: This study presented a multiscale model that incorporated the radiological eigenvalues, genomics features, and CA 19-9, which could be conveniently utilized to facilitate the individualized preoperatively assessing metastasis in CRC patients.
format Online
Article
Text
id pubmed-8113949
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-81139492021-05-13 Individualized Prediction of Colorectal Cancer Metastasis Using a Radiogenomics Approach Liu, Qin Li, Jie Xu, Lin Wang, Jiasi Zeng, Zhaoping Fu, Jiangping Huang, Xuan Chu, Yanpeng Wang, Jing Zhang, Hong-Yu Zeng, Fanxin Front Oncol Oncology Objectives: To evaluate whether incorporating the radiomics, genomics, and clinical features allows prediction of metastasis in colorectal cancer (CRC) and to develop a preoperative nomogram for predicting metastasis. Methods: We retrospectively analyzed radiomics features of computed tomography (CT) images in 134 patients (62 in the primary cohort, 28 in the validation cohort, and 44 in the independent-test cohort) clinicopathologically diagnosed with CRC at Dazhou Central Hospital from February 2018 to October 2019. Tumor tissues were collected from all patients for RNA sequencing, and clinical data were obtained from medical records. A total of 854 radiomics features were extracted from enhanced venous-phase CT of CRC. Least absolute shrinkage and selection operator regression analysis was utilized for data dimension reduction, feature screen, and radiomics signature development. Multivariable logistic regression analysis was performed to build a multiscale predicting model incorporating the radiomics, genomics, and clinical features. The receiver operating characteristic curve, calibration curve, and decision curve were conducted to evaluate the performance of the nomogram. Results: The radiomics signature based on 16 selected radiomics features showed good performance in metastasis assessment in both primary [area under the curve (AUC) = 0.945, 95% confidence interval (CI) 0.892–0.998] and validation cohorts (AUC = 0.754, 95% CI 0.570–0.938). The multiscale nomogram model contained radiomics features signatures, four-gene expression related to cell cycle pathway, and CA 19-9 level. The multiscale model showed good discrimination performance in the primary cohort (AUC = 0.981, 95% CI 0.953–1.000), the validation cohort (AUC = 0.822, 95% CI 0.635–1.000), and the independent-test cohort (AUC = 0.752, 95% CI 0.608–0.896) and good calibration. Decision curve analysis confirmed the clinical application value of the multiscale model. Conclusion: This study presented a multiscale model that incorporated the radiological eigenvalues, genomics features, and CA 19-9, which could be conveniently utilized to facilitate the individualized preoperatively assessing metastasis in CRC patients. Frontiers Media S.A. 2021-04-28 /pmc/articles/PMC8113949/ /pubmed/33996544 http://dx.doi.org/10.3389/fonc.2021.620945 Text en Copyright © 2021 Liu, Li, Xu, Wang, Zeng, Fu, Huang, Chu, Wang, Zhang and Zeng. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Liu, Qin
Li, Jie
Xu, Lin
Wang, Jiasi
Zeng, Zhaoping
Fu, Jiangping
Huang, Xuan
Chu, Yanpeng
Wang, Jing
Zhang, Hong-Yu
Zeng, Fanxin
Individualized Prediction of Colorectal Cancer Metastasis Using a Radiogenomics Approach
title Individualized Prediction of Colorectal Cancer Metastasis Using a Radiogenomics Approach
title_full Individualized Prediction of Colorectal Cancer Metastasis Using a Radiogenomics Approach
title_fullStr Individualized Prediction of Colorectal Cancer Metastasis Using a Radiogenomics Approach
title_full_unstemmed Individualized Prediction of Colorectal Cancer Metastasis Using a Radiogenomics Approach
title_short Individualized Prediction of Colorectal Cancer Metastasis Using a Radiogenomics Approach
title_sort individualized prediction of colorectal cancer metastasis using a radiogenomics approach
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8113949/
https://www.ncbi.nlm.nih.gov/pubmed/33996544
http://dx.doi.org/10.3389/fonc.2021.620945
work_keys_str_mv AT liuqin individualizedpredictionofcolorectalcancermetastasisusingaradiogenomicsapproach
AT lijie individualizedpredictionofcolorectalcancermetastasisusingaradiogenomicsapproach
AT xulin individualizedpredictionofcolorectalcancermetastasisusingaradiogenomicsapproach
AT wangjiasi individualizedpredictionofcolorectalcancermetastasisusingaradiogenomicsapproach
AT zengzhaoping individualizedpredictionofcolorectalcancermetastasisusingaradiogenomicsapproach
AT fujiangping individualizedpredictionofcolorectalcancermetastasisusingaradiogenomicsapproach
AT huangxuan individualizedpredictionofcolorectalcancermetastasisusingaradiogenomicsapproach
AT chuyanpeng individualizedpredictionofcolorectalcancermetastasisusingaradiogenomicsapproach
AT wangjing individualizedpredictionofcolorectalcancermetastasisusingaradiogenomicsapproach
AT zhanghongyu individualizedpredictionofcolorectalcancermetastasisusingaradiogenomicsapproach
AT zengfanxin individualizedpredictionofcolorectalcancermetastasisusingaradiogenomicsapproach